Supriya Lifescience: The financial results for the period ended September 30, 2026
Supriya Lifescience (SUPRIYA) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹6,921 crore.
What happened
Supriya Lifescience (SUPRIYA) filed a disclosure with the exchanges on 6 November 2026 at 12:55 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Supriya Lifescience is a small-cap company in the Healthcare sector, with a market value of about ₹6,921 crore.
The stock last traded at ₹859.9, against a 52-week range of ₹545.5–₹1,085 (20.8% below the high).
Before this filing the shares had moved −4.4% over the month and −5.9% over three months. Average daily turnover over the last 20 sessions was about ₹12.69 crore.
Promoters held 68.30% at the end of Q1 FY27. Foreign institutions owned 6.19% and domestic institutions 5.30%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 145 | 34.8 | 4.32 |
| Q2 FY26 | 200 | 50.4 | 6.27 |
| Q3 FY26 | 206 | 49.7 | 6.17 |
| Q4 FY26 | 277 | 74.2 | 9.22 |
| Q1 FY27 | 190 | 24 | 2.99 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock gained 4.3% on average the next trading day and was up 5.3% on average after five days (3 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 58% of them rose the next day.
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Aug 2026 | A press release dated August 13, 2026, titled "Press Release for… | −3.6% | −1.0% |
| 13 Aug 2026 | 'Unaudited Financial Results for Quarter ended June 30, 2026'. | −3.6% | −1.0% |
| 28 May 2026 | A press release dated May 28, 2026, titled "Press Release - Audited… | +20.0% | +17.9% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.